– USA, OH – HealthPlan Data Solutions, Inc. today announced the appointment of Dale Wollschleger (R.Ph.) to its Board of Directors effective June 28.
Dale Wollschleger founded ExactCare Pharmacy, a CarepathRx Company, in 2009 and served as its CEO for 14 years, with a focus on enabling improved healthcare outcomes through innovative pharmacy solutions. He brings to the HDS Board more than 20 years of experience building, scaling, and transacting within the pharmacy industry.
Dale Wollschleger joins HDS at a critical time as the company continues to scale its SaaS-based solutions for pharmacy payment integrity and campaign management.
“There is a tremendous opportunity for the pharmacy industry to play a leading role in healthcare innovation and enable improved outcomes—both clinical and financial,” said Dale Wollschleger. “HDS provides solutions that meet this challenge and enable payers to optimize their pharmacy benefits management. They are doing remarkable things, and it’s a privilege to join the Board of Directors.”
Wollschleger is a Registered Pharmacist and holds a BS in Pharmacy from Ohio Northern University.
About HealthPlan Data Solutions
HealthPlan Data Solutions is an industry-leading pharmacy analytics company specializing in providing pharmacy payment integrity solutions, campaign management, and pharmacy claims insights. HDS’s technology platform, Spotlight, leverages over 250 proprietary claim scanning algorithms and AI, matched with clinical expertise to provide actionable pharmacy benefit intelligence.
Founded by a team of pharmacists and IT professionals, HDS helps its customers identify, fix, and continuously monitor prescription claims data to maximize the value of their pharmacy benefit plans.
For more information: https://hds-rx.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.